Arotech (ARTX) Sees FY Revenue of $85 to $87 Million
Tweet
Share
E-mailGet Alerts ARTX Hot Sheet
Price: $3.00 --0%
Financial Fact:
Net income (loss): 635.94K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Net income (loss): 635.94K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Arotech Corporation (NASDAQ: ARTX) today provided guidance with respect to its full year 2013 results.
Based on current backlog, customer discussions and order expectations, Arotech expects that 2013 revenues will be in the range of $85 to $87 million. EBITDA for 2013 is expected to be between $2.9 million and $3.4 million.
Based on current backlog, customer discussions and order expectations, Arotech expects that 2013 revenues will be in the range of $85 to $87 million. EBITDA for 2013 is expected to be between $2.9 million and $3.4 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
Create E-mail Alert Related Categories
GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
